Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Last Updated: 10/19/15

Sherry Ansher, Ph.D.

Sherry Ansher

Associate Chief, Agreement Coordination Group

Sherry Ansher is the Associate Chief of the Agreement Coordination Group in the Regulatory Affairs Branch. Dr. Ansher joined CTEP in 1994 after spending a year in the Grants Associates Program of the NIH as the Coordinator of Research and Development Agreements. She is responsible for all of the collaborative agreements for the clinical and nonclinical development of potential anticancer agents by CTEP and the interactions between the investigators, CTEP and the collaborating pharmaceutical companies. Dr. Ansher has a B.S. in Biochemistry from the University of Maryland and a Ph.D. in Biochemical Pharmacology from Johns Hopkins University. Prior to joining NCI, Dr. Ansher worked at the Center for Biologics Evaluation and Research, FDA for 5 years and did her postdoctoral training at the National Institute of Digestive Disorders and Kidney Disease, NIH.

About the Branch Chief

Jan Casadei, PhD Jan Casadei, PhD joined the National Cancer Institute in 1991, where she is now chief of the Regulatory Affairs Branch, CTEP. Her area of expertise covers FDA regulations, policies and guidelines for the conduct of clinical studies with investigational agents. As the chief of the Regulatory Affairs Branch, Dr. Casadei is responsible for facilitating the development of promising investigational anti-cancer agents, by providing regulatory/IND support More…